Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials. J of Skin [Internet]. 2025 Jan. 13 [cited 2025 Oct. 26];9(1):s520. Available from: https://skin.dermsquared.com/skin/article/view/3163